$3.15 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 90 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DFPHU | New | DFP HEALTHCARE ACQUISITNS COunit 03/31/2025 | $103,031,000 | – | 10,460,000 | +100.0% | 3.27% | – |
| New | NUVASIVE INCnote 2.250% 3/1 | $88,732,000 | – | 85,000,000 | +100.0% | 2.82% | – | |
| New | DEXCOM INCnote 0.750%12/0 | $58,922,000 | – | 34,000,000 | +100.0% | 1.87% | – | |
| SDGR | New | SCHRODINGER INC | $58,047,000 | – | 1,346,167 | +100.0% | 1.84% | – |
| PCRX | New | PACIRA BIOSCIENCES | $54,571,000 | – | 1,627,521 | +100.0% | 1.73% | – |
| ABMD | New | ABIOMED INC | $54,580,000 | – | 376,000 | +100.0% | 1.73% | – |
| New | INSMED INCnote 1.750% 1/1 | $50,928,000 | – | 61,000,000 | +100.0% | 1.62% | – | |
| RVMD | New | REVOLUTION MEDICINES INC | $39,359,000 | – | 1,796,383 | +100.0% | 1.25% | – |
| NTRA | New | NATERA INC | $39,296,000 | – | 1,316,000 | +100.0% | 1.25% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $30,067,000 | – | 3,253,960 | +100.0% | 0.95% | – |
| MCK | New | MCKESSON CORP | $23,730,000 | – | 175,437 | +100.0% | 0.75% | – |
| BDSI | New | BIODELIVERY SCIENCES INTL IN | $23,438,000 | – | 6,184,243 | +100.0% | 0.74% | – |
| DXCM | New | DEXCOM INC | $23,426,000 | – | 87,000 | +100.0% | 0.74% | – |
| New | JAZZ INVESTMENTS I LTDnote 1.875% 8/1 | $19,214,000 | – | 20,000,000 | +100.0% | 0.61% | – | |
| New | PACIRA BIOSCIENCESnote 2.375% 4/0 | $19,100,000 | – | 20,000,000 | +100.0% | 0.61% | – | |
| GKOS | New | GLAUKOS CORP | $15,985,000 | – | 517,982 | +100.0% | 0.51% | – |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $13,760,000 | – | 138,874 | +100.0% | 0.44% | – |
| BDTX | New | BLACK DIAMOND THERAPEUTICS I | $13,373,000 | – | 536,001 | +100.0% | 0.42% | – |
| PASG | New | PASSAGE BIO INC | $10,558,000 | – | 670,367 | +100.0% | 0.34% | – |
| VAPO | New | VAPOTHERM INC | $10,483,000 | – | 556,725 | +100.0% | 0.33% | – |
| CERS | New | CERUS CORP | $10,252,000 | – | 2,204,700 | +100.0% | 0.32% | – |
| TARA | New | ARTARA THERAPEUTICS INC | $9,951,000 | – | 432,670 | +100.0% | 0.32% | – |
| AXGN | New | AXOGEN INC | $9,755,000 | – | 937,983 | +100.0% | 0.31% | – |
| APLT | New | APPLIED THERAPEUTICS INC | $9,100,000 | – | 278,359 | +100.0% | 0.29% | – |
| IMRA | New | IMARA INC | $8,015,000 | – | 500,000 | +100.0% | 0.25% | – |
| LUMO | New | LUMOS PHARMA INC | $7,957,000 | – | 936,169 | +100.0% | 0.25% | – |
| New | INTERCEPT PHARMACEUTICALS INnote 2.000% 5/1 | $2,960,000 | – | 3,500,000 | +100.0% | 0.09% | – | |
| CHNG | New | CHANGE HEALTHCARE INC | $2,146,000 | – | 214,789 | +100.0% | 0.07% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $1,941,000 | – | 167,637 | +100.0% | 0.06% | – |
| OXFD | New | OXFORD IMMUNOTEC GLOBAL PLC | $1,430,000 | – | 154,396 | +100.0% | 0.04% | – |
| MLND | New | MILLENDO THERAPEUTICS INC | $892,000 | – | 168,871 | +100.0% | 0.03% | – |
| SYBX | New | SYNLOGIC INC | $654,000 | – | 380,300 | +100.0% | 0.02% | – |
| ELGXQ | New | ENDOLOGIX INC | $656,000 | – | 950,000 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.